Accelerating Drug Discovery for Frontotemporal Degeneration supports researchers and clinicians developing small molecules and biologics to advance disease-modifying treatments for frontotemporal dementia.
Accelerating Drug Discovery for FTD supports investigators developing small molecule and biologic drugs through lead optimization and animal-model testing to advance disease-modifying treatments for FTD.
The Treat FTD Fund from the Alzheimer's Drug Discovery Foundation supports early-stage research and clinical trials to develop new therapies and biomarkers for frontotemporal degeneration.
The Treat FTD Fund supports early-stage clinical trials for innovative FTD treatments, prioritizing biomarker integration and novel trial designs, funded by The Association for Frontotemporal Degeneration.
AFTD Pilot Grants (Well-Being in FTD) support researchers developing new studies to improve well-being for people with FTD, families, and caregivers, and equitable access to diagnosis, care, support, and research.